Difference in Central Fatigue During Two Ultra-endurance Practices: Running vs. Cycling
FAT-CENTR
2 other identifiers
interventional
19
1 country
1
Brief Summary
The mechanisms contributing to muscle fatigue in extreme long-duration exercise bouts are poorly understood. Ultra-endurance exercise is an excellent model for the study of adaptive responses to extreme loads and stress and it is an especially useful model for documenting the origins of central fatigue. This protocol will compare fatigue during and after ultra-endurance exercise bouts that result in moderate lower-limb tissue damage (i.e. cycling) or significant damage (i.e. running). The results of this protocol will allow us to further understanding of the reasons for major central fatigue, i.e. within the central nervous system, in ultra-endurance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2020
CompletedFirst Posted
Study publicly available on registry
August 13, 2020
CompletedStudy Start
First participant enrolled
March 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2021
CompletedNovember 24, 2021
November 1, 2021
3 months
July 31, 2020
November 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximum level of voluntary activation of relative central fatigue
measured in isometric mode of the knee extensors, between the value before and immediately after a 5-hour cycling or running event at the same relative intensity
Before and immediately after 5h exercise
Secondary Outcomes (18)
Maximum level of voluntary activation of fatigue centrale absolute
Before and immediately after 5h exercise
Maximum level of voluntary activation with electrical evoked activation
Before and immediately after 5h exercise
Spinal excitability
Before and immediately after 5h exercise
Corticospinal excitability
Before and immediately after 5h exercise
Cortical excitability
Before and immediately after 5h exercise
- +13 more secondary outcomes
Study Arms (2)
Running endurance
EXPERIMENTALAthletes wiil run for 5 hours in a row.
Cycling endurance
EXPERIMENTALAthletes wiil cycle for 5 hours in a row.
Interventions
Eligibility Criteria
You may qualify if:
- Specialist in endurance and ultra-endurance. in the 2 disciplines: running and cycling (triathletes, duathletes or trailers achieving at least 30% of their training volume in cycling), and having at least finished one long distance event in the last 2 years,
- Affiliated or beneficiary of a social security scheme.
- Signature of the consent form
You may not qualify if:
- Any subject who has been injured in the 3 months prior to the protocol
- Anyone with chronic joint pathologies (e.g.: repetitive sprains, patellar or ligament problems).
- Any subject with chronic or central neurological pathologies
- Any subject with a contraindication to magnetic stimulation
- Use of neuro-active substances likely to alter cortico-spinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) on the study.
- Contraindication to the application of a magnetic field:
- Heart or respiratory insufficiency.
- Subject with a cardiac pace maker.
- Cardiac valve wear and serious cardiovascular diseases.
- Presence of prosthetic material or ferromagnetic foreign bodies in the head.
- Presence of cochlear implants or ocular prosthetic material.
- History of neurosurgical interventions.
- Neurological diseases that may affect brain structures and cognitive abilities (e.g., intracranial tumour, multiple sclerosis, history of stroke or traumatic brain injury).
- History of comitiality, contralateral knee disease or musculoskeletal disease.
- Any subject participating at the same time in another interventional experiment requiring physical exercise.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Saint-Etienne
Saint-Etienne, 42000, France
Study Officials
- PRINCIPAL INVESTIGATOR
Léonard FEASSON, MD PhD
CHU SAINT-ETIENNE
- STUDY DIRECTOR
Guillaume MILLET, PhD
SAINT-ETIENNE UNIVERSITY
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2020
First Posted
August 13, 2020
Study Start
March 5, 2021
Primary Completion
May 28, 2021
Study Completion
July 15, 2021
Last Updated
November 24, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share